We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+15.46%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$8.24M
Cap. Flow
-$3.73M
Cap. Flow %
-3.26%
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
–
Reduced
4
Closed
1
Avg Time Held
5 quarters
Top 10 Avg Time Held
5 quarters
Top 20 Avg Time Held
5 quarters

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$12.5M
2
TXG icon
10x Genomics
TXG
+$8.46M
3
QTRX icon
Quanterix
QTRX
+$6.78M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$20M
2
SONX
Sonendo, Inc.
SONX
+$3.46M
3
ADPT icon
Adaptive Biotechnologies
ADPT
+$3.15M
4
GH icon
Guardant Health
GH
+$2.75M
5
NSTG
NanoString Technologies, Inc.
NSTG
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NTRA icon
1
Natera
NTRA
$59.1B
$24.9M 21.81%
397,436
-400,000
-50% -$20M
2020 Q4
12 quarters
AKYA
2
DELISTED
Akoya BioSciences
AKYA
$22.9M 20.08%
4,697,785
– –
2021 Q4
8 quarters
GH icon
3
Guardant Health
GH
$23.9B
$15.4M 13.53%
571,047
-105,000
-16% -$2.75M
2020 Q4
12 quarters
TMO icon
4
Thermo Fisher Scientific
TMO
$242B
$13.7M 12%
+25,800
New +$12.5M
2023 Q4
0 quarters
TXG icon
5
10x Genomics
TXG
$12.2B
$10.9M 9.53%
+194,500
New +$8.46M
2023 Q4
0 quarters
MXCT icon
6
MaxCyte
MXCT
$110M
$8.86M 7.76%
1,885,000
– –
2022 Q3
5 quarters
ADPT icon
7
Adaptive Biotechnologies
ADPT
$4.52B
$8.27M 7.24%
1,687,665
-690,000
-29% -$3.15M
2022 Q2
6 quarters
QTRX icon
8
Quanterix
QTRX
$172M
$7.88M 6.9%
+288,196
New +$6.78M
2023 Q4
0 quarters
NSTG
9
DELISTED
NanoString Technologies, Inc.
NSTG
$1.31M 1.15%
1,751,891
-2,000,000
-53% -$2.11M
2023 Q2
2 quarters
SONX
10
DELISTED
Sonendo, Inc.
SONX
– –
-4,643,461
Closed -$3.46M –

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Blue Water Life Science Advisors held 10 positions worth $114M, up 7.8% from $106M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $3.73M in Q4 2023, closing 1 position and reducing 4 holdings. Its most notable exit was Sonendo, Inc., an estimated $3.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors opened a new position in Thermo Fisher Scientific worth $13.7M.

  • Blue Water Life Science Advisors's largest Q4 2023 buy was Thermo Fisher Scientific: 25,800 shares worth $13.7M.
  • Blue Water Life Science Advisors's biggest Q4 2023 reduction was Natera, cutting an estimated $20M.
  • Blue Water Life Science Advisors fully exited Sonendo, Inc. in Q4 2023, selling an estimated $3.46M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $114M portfolio in Q4 2023.
  • Blue Water Life Science Advisors opened 3 new positions and closed 1 in Q4 2023.
  • Blue Water Life Science Advisors's portfolio value rose 7.8% quarter-over-quarter to $114M.

Based on Blue Water Life Science Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.